SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

New-onset psychosis due to COVID-19.

Kozato, N; Mishra, M; Firdosi, M (2021) New-onset psychosis due to COVID-19. BMJ Case Rep, 14 (4). e242538. ISSN 1757-790X https://doi.org/10.1136/bcr-2021-242538
SGUL Authors: Firdosi, Muhammad Mudasir

[img] Microsoft Word (.docx) Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (36kB)

Abstract

This is a case report of a middle-aged man with no psychiatric history who presented with severe anxiety and psychotic symptoms from COVID-19. Following his discharge from intensive care unit, he was unable to sleep, was increasingly agitated and was observed hitting his head off the walls, causing haematomas. He remained highly anxious and developed paranoid delusions and auditory and tactile hallucinations, needing admission to a psychiatric ward. Treatment with antipsychotic medication gradually improved his symptoms in a few weeks. This case report highlights the new onset of psychosis due to COVID-19 infection. It demonstrates the importance of early identification and treatment of neuropsychiatric complications within an acute hospital setting. Furthermore, there is a need for research in this area to help in the prevention and treatment of such psychiatric complications due to COVID-19.

Item Type: Article
Additional Information: This article has been accepted for publication in BMJ Case Reports, 2021 following peer review, and the Version of Record can be accessed online at http://dx.doi.org/10.1136/bcr-2021-242538 © BMJ Publishing Group Limited 2021.
Keywords: COVID-19, psychiatry, psychiatry (drugs and medicines), Antipsychotic Agents, COVID-19, Delusions, Humans, Male, Middle Aged, Psychotic Disorders, SARS-CoV-2, Treatment Outcome, Humans, Antipsychotic Agents, Treatment Outcome, Delusions, Psychotic Disorders, Middle Aged, Male, COVID-19, SARS-CoV-2, COVID-19, psychiatry, psychiatry (drugs and medicines)
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Journal or Publication Title: BMJ Case Rep
ISSN: 1757-790X
Language: eng
Dates:
DateEvent
26 April 2021Published
15 April 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
PubMed ID: 33906867
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113397
Publisher's version: https://doi.org/10.1136/bcr-2021-242538

Statistics

Item downloaded times since 07 Jul 2021.

Actions (login required)

Edit Item Edit Item